SR
CL icon

Syntax Research’s Colgate-Palmolive CL Stock Holding History

Syntax Research’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-165
Closed -$13K – 176
2025
Q4 		$13K Hold
165
– – 0.01% 138
2025
Q3 		$13.2K Hold
165
– – 0.01% 137
2025
Q2 		$15K Hold
165
– – 0.01% 121
2025
Q1 		$15.5K Hold
165
– – 0.01% 126
2024
Q4 		$15K Hold
165
– – 0.01% 128
2024
Q3 		$17.1K Hold
165
– – 0.01% 128
2024
Q2 		$16K Hold
165
– – 0.01% 121
2024
Q1 		$14.9K Hold
165
– – 0.01% 124
2023
Q4 		$13.2K Sell
165
-20
-11% -$1.5K 0.01% 127
2023
Q3 		$13.2K Buy
+185
New +$13.8K 0.01% 132

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Syntax Research's CL Position: Q1 2026 in Review

Syntax Research sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 165 shares — an estimated $13K sold.

Syntax Research first reported a position in CL in Q3 2023 and held it in 10 quarters. The position peaked at $17.1K in Q3 2024. 1,961 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Syntax Research reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
  • Syntax Research sold 165 Colgate-Palmolive shares in Q1 2026, an estimated $13K.
  • Syntax Research first reported a position in Colgate-Palmolive in Q3 2023 and held it in 10 quarters.
  • Syntax Research's Colgate-Palmolive position peaked at $17.1K in Q3 2024.
  • 1,961 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Syntax Research's 13F filing for Q1 2026, filed 24 Apr 2026.